Bloomberg News

Tigenix to Get 4.95 Million-Euro Loan for Crohn’s Fistula Study

October 03, 2011

Oct. 3 (Bloomberg) -- TiGenix NV’s Cellerix unit will get a 4.95 million-euro loan from the “Madrid Network” to finance the company’s phase III study for complex perianal fistulas in Crohn’s disease patients, TiGenix said today in an e-mailed statement.

To contact the editor responsible for this story: Andrew Clapham at aclapham@bloomberg.net


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus